title: Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis.
authors.affiliation: London Regional Cancer Program, London, Ontario. Ted.Vandenberg@lhsc.on.ca
authors.forename: T
authors.initials: T
authors.lastname: Vandenberg
authors.forename: J
authors.initials: J
authors.lastname: Younus
authors.forename: S
authors.initials: S
authors.lastname: Al-Khayyat
references.citation: J Clin Oncol. 2006 Jul 1;24(19):3187-205
references.pmid: 16682719
references.citation: JAMA. 2005 Mar 2;293(9):1073-81
references.pmid: 15741529
references.citation: J Clin Oncol. 2006 Dec 1;24(34):5381-7
references.pmid: 17135639
references.citation: Ann Intern Med. 2007 Sep 18;147(6):400-11
references.pmid: 17876022
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1177-83
references.pmid: 19204201
references.citation: J Clin Oncol. 2008 Jan 1;26(1):44-53
references.pmid: 18165639
references.citation: J Clin Oncol. 2009 May 1;27(13):2170-6
references.pmid: 19307509
references.citation: Lancet. 2008 Jan 5;371(9606):29-40
references.pmid: 18177773